Trademark Overview
On Friday, November 19, 2004, a trademark application was filed for CELTYMAX with the United States Patent and Trademark Office. The USPTO has given the CELTYMAX trademark a serial number of 78520036. The federal status of this trademark filing is ABANDONED - EXPRESS as of Monday, February 21, 2005. This trademark is owned by Novartis AG. The CELTYMAX trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of disorders of the nervrous system, the immune system, the cardiovascular system, the respiratory system, the cardiovascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in hematology, in oncology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations treating bacterial-based disease, antivirals, antibiotics, and antifungals